ArticleCurrent microbiology2025
Synergistic Effects of 5-Ureidohydantoin, Rhizobacteria and Non-wood-Based Biochar on Barley Productivity Under Drought and Multiple Toxic Metals Stress.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Barely (Hordeum vulgare L.), an essential crop accounting for roughly 15% of global caloric consumption, confronts substantial risks from toxic metal pollution, especially drought stress, (Pb) and mercury (Hg) stress, endangering global food safety. The current research sought to examine synergistic impacts of abovementioned stressors and efficacy of 5-ureidohydantoin, rhizobacteria and non-wood-based biochar in promoting barley growth. Experimental design comprised 24 treatment combinations featuring drought stress, Pb stress (5 mg/kg) and Hg stress (250 and 500 mg/kg) with diverse administrations of biochar and 5-ureidohydantoin. Rhizobacteria and 5-ureidohydantoin combination increase barley growth by promoting root development, enhancing nutrient absorption and improving overall vitality, with 5-ureidohydantoin facilitating cell division and elongation, while rhizobacteria enhance nutrient accessibility and root integrity, resulting in an expedited germination process, flowering and yields. Barley seeds cv. TJ-70, subjected to Agrobacterium rhizogenes treatment, exhibited notable growth parameters, with root lengths measuring 10.01 cm under 5 mg/kg Pb stress than 6.31 cm in control group. The treatment enhanced root and shoot FW by 23.7% 25.71%, respectively, whereas chlorophyll content reached a maximum of 2.69 mg/g at 5 mg/kg Pb. Research revealed that plants exposed to rhizobacteria and 5-ureidohydantoin had substantial enhancements in germination rate (over 85%), root length (averaging 27 cm), shoot length (averaging 29 cm) and total biomass in comparison to control treatments. The simultaneous application of 5-ureidohydantoin and jute-biochar exhibited significant promise for enhancing barley's resistance to metals and drought stresses by increased chlorophyll levels and decreased EL in amended plants. Furthermore, electrolyte leakage diminished to 11.4%, and the vigor index enhanced to 1601.09 under Pb stress. These data suggest that biochar and 5-ureidohydantoin use can alleviate detrimental impacts of environmental stresses on barley. Extending this study to encompass various crops will facilitate evaluation of wider relevance of these results; thereby fostering integrated crops management tactics utilize stimulants such as rhizobacteria and 5-ureidohydantoin in conjunction with organic and inorganic amendments, ultimately enhancing agricultural resilience and global food security.
Indexed as
Identifiers
40473856What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.